Evidence map›Paper›PMID 35224681›Full record

ArticleUpdates in surgery2022

Predicting resectability of primary tumor and mesenteric lymph-node masses in patients with small-intestine neuroendocrine tumors.

Emilio Bertani, Fabio Zugni, Davide Radice, Francesca Spada, Guido Bonomo, Uberto Fumagalli Romario, Nicola Fazio, Luigi Funicelli

Abstract read
PubMed Publisher
In one paragraph

Article in Updates in surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Emilio BertaniDivision of Digestive Surgery, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti, 435, 20141, Milan, Italy. emilio.bertani@ieo.it.ORCID http://orcid.org/0000-0002-3608-1995
Fabio ZugniDivision of Radiology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Davide RadiceDivision of Epidemiology and Biostatistics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Francesca SpadaDivision of Gastrointestinal and Neuroendocrine Tumors Medical Treatment, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Guido BonomoDivision of Interventional Radiology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Uberto Fumagalli RomarioDivision of Digestive Surgery, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti, 435, 20141, Milan, Italy.
Nicola FazioDivision of Gastrointestinal and Neuroendocrine Tumors Medical Treatment, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Luigi FunicelliDivision of Radiology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
European Institute of Oncology · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITRipamonti · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVascular infiltration may jeopardize resection of the primary tumor and mesenteric metastatic masses in small-intestine neuroendocrine tumors (SI-NETs). However, other factors may play a role in predicting resectability.

methodsAfter computed tomography (CT) scan, three radiological parameters were considered: (1) degree of superior mesenteric artery involvement (SMA) according to a previous classification (2) degree of superior mesenteric venous involvement (SMV) as either absent, peripheral or proximal (3) presence or not of mesenteric fibrosis retraction (MF). Pre-surgical parameters were matched to surgical outcome.

resultsForty-nine consecutive patients were submitted to laparotomy. Of them, 37 had complete primary tumor and mesenteric masses resection. SMA (p = 0.001), SMV (p = 0.008), metastasis site (p = 0.001) and MF (p < 0.001) were all significantly associated with the likelihood to receive resection at univariate analysis. All the five patients with infiltration of SMV proximal to middle colic vein were unresectable. At multivariable analysis excluding SMA stage, the absence of MF (HR 13.1, I.C. 1.44-119; p = 0.002) was the only factor associated with the likelihood to receive primary tumor and mesentery radical surgery.

conclusionsSMA stage 3-up and/or signs of MF, as well as infiltration of SMV proximal to middle colic vein at CT scan are predictive of operative failure in patients with SI-NETs. The assessment of such factors should be always considered in the decision-making process of such patients especially in those with asymptomatic disease with synchronous unresectable liver metastases.

Indexed as

ColicNeuroendocrine TumorsHumansIntestinesMesenteric VeinsMesenteryLiver metastasesLiver resectionPrimary tumor resectionSmall intestine neuroendocrine tumors

Identifiers

PMID35224681
OpenAlexW4214679221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.